Please login to the form below

Teva and Novartis settle patent lawsuit

Teva Pharmaceuticals will settle patent litigation with Novartis involving Teva's US generic version of antiviral medication Famvir

Teva Pharmaceuticals, US, has signed an agreement with Novartis to settle patent litigation involving Teva's US generic version of the Novartis-developed antiviral medication Famvir (famciclovir).

The settlement includes all claims for patent infringement and damages.

Under the terms of the agreement, Israel-based Teva will make an undisclosed one-time payment to Novartis plus ongoing royalties on US sales of its product, which is used to treat herpes and shingles.

Teva is among the top 15 global pharmaceutical companies and is a leading generic pharmaceutical company. Teva launched the generic version of Famvir in September 2007.

16th February 2010

PME Digital Edition

Featured jobs

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Account Executive/ Senior Account Executive: competitive Salary Offfered

Business Director: Competitive Salary Offered

Principal Health Economist - North-West: Negotiable

Systematic Reviewer - Oxford: Negotiable

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Medical (Scientific) Director: £120, 000 benefits

Medical Writer: Salary TBC

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Associate Director: £75, 000-90, 000

Healthcare Communications Account Directors x 2: Salary TBC

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Senior Account Manager: Competitive Salary Offered

Experienced Medical Writers: Competitive Salary and Benefits

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Manager / Account Director: Competative

Account Manager- Healthcare Advertising: Negotiable

Editorial Manager - MedComms: DOE

Account Director – Healthcare Marketing – Berks: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Account Manager: Negotiable

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Business Development Director – Health Education: excellent commission

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...